Skip to content
February 03, 2023

Equity.Guru

Investment information for the new generation

October 19, 2021

A few months ago, I spoke about the Coinbase IPO being a watershed moment for cryptocurrencies. Well, let’s add another date to the history books. October 19th 2021 is…
‘Gold-rich zone‘ – ‘Open-ended mineralization‘ – ‘Areas previously untested by historic drilling‘… when a junior explorer trots out this kind of wordage in the intro of a communique, pay…
Business Overview Canntab Therapeutics is a Canadian biopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations….
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Canntab Therapeutics (PILL.CN) is a Canadian biopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. Canntab’s…
Canntab Therapeutics (PILL.C) has been around the block and then some. The Ontario-based pharmaceutical answer to medicinal cannabis, has pioneered a patented process to turn CBD, THC and terpene…